Would you like to participate in a vascular research study?
Please scroll down to discover active vascular studies open to patient recruitment. If you would like to take part in any of the studies below, please use the button provided with the study advertisement to contact the research team directly.
AAA Studies
GRASP study - open for recruitment until June 2026
Can you spare some time to take part in a research study to improve the NHS Abdominal Aortic Aneurysm (AAA) screening programme?
The NHS's AAA screening programme invites men aged 65 to attend a local clinic for an ultrasound scan to check them for AAA. One of the things that can increase the risk of someone having an AAA is their genetics and DNA.
The GRASP Study team are looking for men aged 60 -70 to take part in a one-off online interview.
We want to know how you feel about using information from your DNA in the pathways and invitations for AAA screening.
For further information and to take part in our research please contact the study team by clicking the button below:
UK-MAT trial - Recruitment end date: June 2028
Abdominal Aortic Aneurysm (AAA) is a common problem in older adults, affecting approximately 5% of men and 1% of women over the age of 60. Over time, there is a risk that the AAA increases in size to the point where it requires surgical intervention, or it can rupture, which is life threatening and requires emergency surgery. Other than surgery, there is currently no known effective treatment to treat AAA’s.
The Metformin Aneurysm Trial (UK-MAT) is a randomised control trial taking place at multiple UK vascular centres. It is seeking to explore the impact of the drug Metformin (commonly used in the treatment of Type 2 diabetes) on non-diabetic patients who have been diagnosed with a small Abdominal Aortic Aneurysm (AAA), and are currently attending AAA screening.
To be eligible to participate in the study, individuals must have a AAA below the size of 49mm, diagnosed by imaging though a registered healthcare provider, and have no AAA surgical procedure planned within 12 months. They must be aged over 18, non-diabetic, and should not currently take Metformin.
To discover if your local vascular centre is taking part in the UK-MAT trial, and to find out if you would be eligible to participate in the trial, please contact the study team by clicking the button below.